Women Also Use 5α-Reductase Inhibitors

November 2017 in “ JAMA internal medicine ”

Siddika E Karakas

5α-reductase inhibitors hirsutism alopecia estrogen male hypogonadism female hyperandrogenism testosterone inhibition 5-alpha-reductase inhibitors hair loss high estrogen low testosterone high androgens

Studysummary This letter to the editor states that the titles of two recent pieces in JAMA Internal Medicine should have included "in Men.

Automatically generated from the study's abstract, not written by a person, and not a review of the full paper. Not medical advice or a treatment recommendation. Read the original study, and consult a qualified healthcare professional before changing treatment. Full disclaimer

View this study on jamanetwork.com →

Discuss this study in the Community →

Research cited in this study

3 / 3 results

research Association of Suicidality and Depression With 5α-Reductase Inhibitors

90 citations , March 2017 in “JAMA Internal Medicine”

In this study, older men using 5α-reductase inhibitors for prostatic enlargement did not show increased risk of suicide, but had elevated risks of self-harm and depression.

research Finasteride 5 mg/Day Treatment of Patterned Hair Loss in Normo-Androgenetic Postmenopausal Women

44 citations , January 2013 in “International Journal of Trichology”

This study found that 5 mg/day oral finasteride was effective and safe for improving hair outcomes in normoandrogenic postmenopausal women with androgenetic alopecia over 18 months.

research Comparison of High-Dose Finasteride (5 mg/day) Versus Low-Dose Finasteride (2.5 mg/day) in the Treatment of Hirsutism

51 citations , October 2002 in “European journal of endocrinology”

This study found that both high-dose and low-dose finasteride significantly reduced hirsutism scores in women after 12 months, with the lower dose being safe and cost-effective.